#1 Clinical Trials Search in Europe

Olmesartan Medoxomil

Olmesartan Medoxomil, an angiotensin II receptor blocker, has been the subject of numerous clinical trials exploring its efficacy in treating hypertension and other related conditions. This article summarizes key findings from recent studies, highlighting the drug’s potential benefits, safety profile, and applications in various patient populations.

Table of Contents

What is Olmesartan Medoxomil?

Olmesartan Medoxomil is a medication primarily used to treat high blood pressure (hypertension). It belongs to a class of drugs called angiotensin II receptor blockers (ARBs). This medication is also known by brand names such as Benicar, Olartan, and CS-866[1][2].

Olmesartan Medoxomil is a prodrug, which means it’s inactive when you take it, but your body converts it into the active form called olmesartan. This conversion happens in your intestines, blood, and liver through a process called de-esterification[1].

What Conditions Does Olmesartan Medoxomil Treat?

Olmesartan Medoxomil is primarily used to treat:

  • Essential Hypertension: This is the medical term for high blood pressure with no identifiable cause. It’s the most common form of hypertension[3].
  • Diabetic Nephropathy: This is kidney damage that can occur in people with diabetes[4].
  • Chronic Glomerulonephritis: A type of kidney disease caused by inflammation of the glomeruli, which are tiny filters in your kidneys[4].

Some studies are also investigating its potential benefits for patients with metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and diabetes[5].

How Does Olmesartan Medoxomil Work?

Olmesartan Medoxomil works by blocking the action of a hormone called angiotensin II. This hormone normally causes blood vessels to narrow, which can increase blood pressure. By blocking this hormone, olmesartan allows blood vessels to relax and widen, lowering blood pressure[6].

Recent research suggests that olmesartan might also increase the activity of an enzyme called ACE-2 and raise levels of a substance called angiotensin(1-7). These effects might provide additional benefits beyond just lowering blood pressure, such as protecting the heart and blood vessels[6].

Dosage and Administration

Olmesartan Medoxomil is typically taken once daily as an oral tablet. The dosage can vary depending on the individual patient and their condition. Common dosages include:

  • Starting dose: 20 mg once daily
  • Usual dose range: 20-40 mg once daily
  • Maximum dose: 40 mg once daily[7]

In some cases, olmesartan may be combined with other blood pressure medications, such as hydrochlorothiazide (a diuretic), for better blood pressure control[8].

Effectiveness of Olmesartan Medoxomil

Olmesartan Medoxomil has been shown to be effective in lowering both systolic (the top number) and diastolic (the bottom number) blood pressure. Its effectiveness has been demonstrated in various patient populations, including:

  • Adults with mild to moderate hypertension[3]
  • Children and adolescents with hypertension[2]
  • Patients with diabetes and kidney disease[4]

Studies have shown that olmesartan can provide 24-hour blood pressure control with once-daily dosing, which is important for consistent management of hypertension[1].

Potential Side Effects

Like all medications, Olmesartan Medoxomil can cause side effects, although not everyone experiences them. Common side effects may include:

  • Dizziness
  • Headache
  • Fatigue
  • Nausea
  • Upper respiratory tract infections[7]

More serious side effects are rare but can include severe allergic reactions, kidney problems, or high potassium levels in the blood. It’s important to discuss any side effects with your healthcare provider[7].

Drug Interactions

Olmesartan Medoxomil can interact with other medications. One study investigated its interaction with probenecid, a medication used to treat gout. While olmesartan generally has a low risk of drug interactions, it’s important to inform your healthcare provider about all medications you’re taking[1].

Use in Special Populations

Olmesartan Medoxomil has been studied in various patient groups:

  • Children and Adolescents: It has been shown to be effective and safe in children as young as 1 year old with hypertension[2].
  • Elderly Patients: The medication’s effects are not significantly affected by age[1].
  • Patients with Kidney Disease: Olmesartan may have protective effects on the kidneys, particularly in patients with diabetes[4].

Ongoing Research and Future Perspectives

Research on Olmesartan Medoxomil is ongoing, with studies exploring its potential benefits beyond blood pressure control. Some areas of investigation include:

  • Its effects on arterial stiffness and thickness in patients with metabolic syndrome[5].
  • Its impact on levels of angiotensin(1-7) and vascular function in patients with diabetes and hypertension[6].
  • Comparison with new medications for hypertension, such as Sacubitril Allisartan medoxomil[9].

These studies may provide new insights into the full range of benefits that Olmesartan Medoxomil can offer to patients with hypertension and related conditions.

Aspect Details
Primary Use Treatment of hypertension (high blood pressure)
Mechanism of Action Angiotensin II receptor blocker (ARB)
Patient Populations Studied Adults, children, adolescents, patients with metabolic syndrome, diabetic nephropathy
Dosage Forms Oral tablets, suspension
Combination Therapies Studied with hydrochlorothiazide for enhanced efficacy
Additional Potential Benefits Arterial protection, reduction in proteinuria in kidney diseases
Safety Profile Generally well-tolerated; common side effects include dizziness, headache
Ongoing Research Areas Effects on angiotensin(1-7) levels, vascular function in diabetes

FAQ

  • What is Olmesartan Medoxomil used for? Olmesartan Medoxomil is primarily used to treat high blood pressure (hypertension). It's also being studied for potential benefits in conditions like metabolic syndrome, chronic glomerulonephritis, and diabetic nephropathy.
  • How does Olmesartan Medoxomil work? Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB). It works by blocking the action of angiotensin II, a substance in the body that causes blood vessels to tighten. This helps relax blood vessels, lowering blood pressure.
  • Is Olmesartan Medoxomil safe for children? Some clinical trials have studied Olmesartan Medoxomil in children and adolescents with hypertension. However, its use in pediatric patients should be under strict medical supervision and as prescribed by a doctor.
  • Can Olmesartan Medoxomil be combined with other medications? Yes, some studies have explored combining Olmesartan Medoxomil with other medications like hydrochlorothiazide for enhanced blood pressure control. However, any combination therapy should be under a doctor's guidance.
  • What are the potential side effects of Olmesartan Medoxomil? While generally well-tolerated, potential side effects may include dizziness, headache, and fatigue. Clinical trials also monitor for any serious adverse events. Always consult your healthcare provider about potential side effects.

Ongoing Clinical Trials on Olmesartan Medoxomil

  • Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on Predicting Blood Pressure Response in Hypertension Patients Using Amlodipine, Olmesartan Medoxomil, Hydrochlorothiazide, and Drug Combination

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    1 1
    Investigated drugs:
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Italy Portugal +1

Glossary

  • Angiotensin II receptor blocker (ARB): A type of medication that blocks the action of angiotensin II, a hormone that causes blood vessels to narrow. ARBs help blood vessels relax and widen, lowering blood pressure.
  • Hypertension: Also known as high blood pressure, it's a condition where the force of blood against artery walls is consistently too high, potentially leading to health problems.
  • Metabolic syndrome: A cluster of conditions occurring together, including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels, which increase the risk of heart disease, stroke, and diabetes.
  • Nephropathy: A general term for kidney disease or damage. Diabetic nephropathy refers to kidney damage caused by diabetes.
  • Pulse wave velocity (PWV): A measure of arterial stiffness, which is an important indicator of cardiovascular health and a predictor of future cardiovascular events.
  • Intima-media thickness (IMT): A measurement of the thickness of the inner two layers of the carotid artery wall, used as an early indicator of atherosclerosis.
  • Creatinine clearance (Ccr): A test that measures how well your kidneys are working by estimating how much blood the kidneys can filter in a minute.
  • Angiotensin-converting enzyme 2 (ACE-2): An enzyme that generates small proteins that then regulate functions in the body, playing a role in blood pressure regulation and inflammation.

References

  1. https://clinicaltrials.gov/study/NCT01907373
  2. https://clinicaltrials.gov/study/NCT00151775
  3. https://clinicaltrials.gov/study/NCT00872586
  4. https://clinicaltrials.gov/study/NCT00914524
  5. https://clinicaltrials.gov/study/NCT00676845
  6. https://clinicaltrials.gov/study/NCT05189015
  7. https://clinicaltrials.gov/study/NCT01200407
  8. https://clinicaltrials.gov/study/NCT00796159
  9. https://clinicaltrials.gov/study/NCT05033535